AJP - Heart Watch the video to see how APS reaches out to developing nations.
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol 295: H2541-H2550, 2008. First published October 31, 2008; doi:10.1152/ajpheart.01052.2008
0363-6135/08 $8.00
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
295/6/H2541    most recent
01052.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Liu, J.
Right arrow Articles by Wang, X.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Liu, J.
Right arrow Articles by Wang, X.

A therapeutic dose of doxorubicin activates ubiquitin-proteasome system-mediated proteolysis by acting on both the ubiquitination apparatus and proteasome

Jinbao Liu,1,2 Hanqiao Zheng,2 Mingxin Tang,2 Youn-Chul Ryu,2 and Xuejun Wang1,2

1Guangzhou Medical College, Guangzhou, Guangdong, China; and 2Sanford School of Medicine, University of South Dakota, Vermillion, South Dakota

Submitted 1 October 2008 ; accepted in final form 29 October 2008

The ubiquitin proteasome system (UPS) degrades abnormal proteins and most unneeded normal proteins, thereby playing a critical role in protein homeostasis in the cell. Proteasome inhibition is effective in treating certain forms of cancer, while UPS dysfunction is increasingly implicated in the pathogenesis of many severe and yet common diseases. It has been previously shown that doxorubicin (Dox) enhances the degradation of a UPS surrogate substrate in mouse hearts. To address the underlying mechanism, in the present study, we report that 1) Dox not only enhances the degradation of an exogenous UPS reporter (GFPu) but also antagonizes the proteasome inhibitor-induced accumulation of endogenous substrates (e.g., β-catenin and c-Jun) of the UPS in cultured NIH 3T3 cells and cardiomyocytes; 2) Dox facilitates the in vitro degradation of GFPu and c-Jun by the reconstituted UPS via the enhancement of proteasomal function; 3) Dox at a therapeutically relevant dose directly stimulates the peptidase activities of purified 20S proteasomes; and 4) Dox increases, whereas proteasome inhibition decreases, E3 ligase COOH-terminus of heat shock protein cognate 70 in 3T3 cells via a posttranscriptional mechanism. These new findings suggest that Dox activates the UPS by acting directly on both the ubiquitination apparatus and proteasome.

cardiomyocytes; COOH-terminus of heat shock protein cognate 70-interacting protein; heat shock protein 70



Address for reprint requests and other correspondence: J. Liu, Dept. of Pathophysiology, Guangzhou Medical College, 195 W. Dongfeng Rd., Guangzhou, Guangdong, China (e-mail: liujinbaol{at}yahoo.com.cn); and X. Wang, Div. of Basic Biomedical Science, Sanford School of Medicine, Univ. of South Dakota, 414 E. Clark St., Lee Medical Bldg., Vermillion, SD 57069 (e-mail: Xuejun.Wang{at}usd.edu)




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
N. Hedhli and C. Depre
Proteasome inhibitors and cardiac cell growth
Cardiovasc Res, January 15, 2010; 85(2): 321 - 329.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online
Copyright © 2008 by the American Physiological Society.